There have been no open-market insider trades at Walgreens Boots Alliance, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. Members of Congress reported 5 trades in WBA over the past two years (four members).
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | Pessina Stefano | Chair | Sell | 832,258 | $11.01 | $9.2M | SEC |
| Apr 29, 2025 | Pessina Stefano | Chair | Buy | 832,258 | $11.01 | $9.2M | SEC |
| Apr 15, 2024 | Bhandari Inderpal S | Director | Buy | 3,000 | $18.05 | $54K | SEC |
| Apr 2, 2024 | Mahajan Manmohan | CFO | Buy | 6,000 | $19.38 | $116K | SEC |
| Jan 31, 2024 | JARRETT VALERIE B | Director | Buy | 4,456 | $22.44 | $100K | SEC |
| Jan 18, 2024 | SCHLICHTING NANCY M | Director | Sell | 15,209 | $23.05 | $351K | SEC |
| Jan 8, 2024 | WENTWORTH TIMOTHY C | CEO | Buy | 10,000 | $24.22 | $242K | SEC |
| Nov 14, 2023 | Gates Richard P. | Executive Officer | Sell | 1,000 | $20.45 | $20K | SEC |
| Jul 5, 2023 | DRISCOLL JOHN PATRICK | Executive Officer | Buy | 5,172 | $28.42 | $147K | SEC |
| Mar 31, 2023 | BREWER ROSALIND G | CEO | Buy | 10,000 | $33.95 | $340K | SEC |
| Filed | Member | Type | Amount | Source |
|---|---|---|---|---|
| Aug 5, 2026 | Tommy Tuberville R | Purchase | $15,001 - $50,000 | Official filing |
| Sep 12, 2025 | Val T. Hoyle D | Sale | $1,001 - $15,000 | Official filing |
| Mar 12, 2025 | Julie Johnson D | Sale | $1,001 - $15,000 | Official filing |
| Mar 6, 2025 | Gilbert Ray Cisneros, Jr. D | Sale | $1,001 - $15,000 | Official filing |
| Feb 12, 2025 | Julie Johnson D | Purchase | $1,001 - $15,000 | Official filing |
There were no open-market insider trades in WBA in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
Yes. Members of Congress reported 5 trades in WBA over the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).